Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The document concludes that over 500 genes are linked to hair disorders and this knowledge is important for creating new treatments.

Scientists have found specific genes linked to different hair loss conditions, which could lead to new treatments.

Androgenetic alopecia is common hair loss caused by genetics and hormones, with treatments mainly slowing it down.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

A genetic test can identify people at risk of male pattern baldness early, allowing for quicker treatment.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Tunisian children with hereditary vitamin D-resistant rickets showed improvement with calcium treatment, and new genetic mutations were identified.

Minoxidil improved hair growth in a child with a rare genetic disorder.

Skin pigmentation varies due to genetics, UV exposure, and drugs, with treatments available but requiring medical advice.

The article explains the genetic causes and symptoms of various hair disorders and highlights the need for more research to find treatments.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

Electrophoresis can effectively analyze hair proteins for forensic use, even after cosmetic treatments and up to 2 years of weathering.

Androgenetic alopecia is influenced by multiple genes and pathways, with genetic risk varying by population, and personalized treatments are being explored.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

New treatments like low-level laser therapy, platelet-rich plasma therapy, and micro needling show positive results for hair regrowth in people with genetic hair loss.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Mutations in keratin genes cause skin disorders, but new treatments show promise.

Topical minoxidil helped an 8-year-old boy with a genetic hair disorder grow hair.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

Concentrated growth factors may help treat hair loss caused by genetics.

The document concludes that understanding the genes and pathways involved in hair growth is crucial for developing treatments for hair diseases.

Topical minoxidil may help treat a rare genetic hair condition with no fully effective treatments yet.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Early genetic testing and new therapies like secukinumab are crucial for managing Netherton syndrome effectively.